234 related articles for article (PubMed ID: 21921030)
1. Generation of N-ethyl-N-nitrosourea (ENU) diabetes models in mice demonstrates genotype-specific action of glucokinase activators.
Fenner D; Odili S; Hong HK; Kobayashi Y; Kohsaka A; Siepka SM; Vitaterna MH; Chen P; Zelent B; Grimsby J; Takahashi JS; Matschinsky FM; Bass J
J Biol Chem; 2011 Nov; 286(45):39560-72. PubMed ID: 21921030
[TBL] [Abstract][Full Text] [Related]
2. Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes.
Al-Oanzi ZH; Fountana S; Moonira T; Tudhope SJ; Petrie JL; Alshawi A; Patman G; Arden C; Reeves HL; Agius L
Diabetes Obes Metab; 2017 Aug; 19(8):1078-1087. PubMed ID: 28206714
[TBL] [Abstract][Full Text] [Related]
3. A new mouse model of type 2 diabetes, produced by N-ethyl-nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene.
Toye AA; Moir L; Hugill A; Bentley L; Quarterman J; Mijat V; Hough T; Goldsworthy M; Haynes A; Hunter AJ; Browne M; Spurr N; Cox RD
Diabetes; 2004 Jun; 53(6):1577-83. PubMed ID: 15161764
[TBL] [Abstract][Full Text] [Related]
4. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
Song Y; Sui T; Zhang Y; Wang Y; Chen M; Deng J; Chai Z; Lai L; Li Z
Cell Mol Life Sci; 2020 Aug; 77(16):3265-3277. PubMed ID: 31720743
[TBL] [Abstract][Full Text] [Related]
5. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
[TBL] [Abstract][Full Text] [Related]
6. Insight into the biochemical characteristics of a novel glucokinase gene mutation.
Shen Y; Cai M; Liang H; Wang H; Weng J
Hum Genet; 2011 Mar; 129(3):231-8. PubMed ID: 21104275
[TBL] [Abstract][Full Text] [Related]
7. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis program.
Inoue M; Sakuraba Y; Motegi H; Kubota N; Toki H; Matsui J; Toyoda Y; Miwa I; Terauchi Y; Kadowaki T; Shigeyama Y; Kasuga M; Adachi T; Fujimoto N; Matsumoto R; Tsuchihashi K; Kagami T; Inoue A; Kaneda H; Ishijima J; Masuya H; Suzuki T; Wakana S; Gondo Y; Minowa O; Shiroishi T; Noda T
Hum Mol Genet; 2004 Jun; 13(11):1147-57. PubMed ID: 15102714
[TBL] [Abstract][Full Text] [Related]
8. Enhanced oxidative stress and endocrine pancreas alterations are linked to a novel glucokinase missense mutation in ENU-derived Munich Gck(D217V) mutants.
van Buerck L; Schuster M; Rathkolb B; Sabrautzki S; Hrabě de Angelis M; Wolf E; Aigner B; Wanke R; Herbach N
Mol Cell Endocrinol; 2012 Oct; 362(1-2):139-48. PubMed ID: 22698525
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of a glucokinase point mutant in the treatment of diabetes mellitus.
Lu G; Teng X; Zheng Z; Zhang R; Peng L; Zheng F; Liu J; Huang H; Xiong H
Gene Ther; 2016 Apr; 23(4):323-9. PubMed ID: 26752353
[TBL] [Abstract][Full Text] [Related]
10. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
Valentínová L; Beer NL; Staník J; Tribble ND; van de Bunt M; Hučková M; Barrett A; Klimeš I; Gašperíková D; Gloyn AL
PLoS One; 2012; 7(4):e34541. PubMed ID: 22493702
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic severity of homozygous GCK mutations causing neonatal or childhood-onset diabetes is primarily mediated through effects on protein stability.
Raimondo A; Chakera AJ; Thomsen SK; Colclough K; Barrett A; De Franco E; Chatelas A; Demirbilek H; Akcay T; Alawneh H; ; Flanagan SE; Van De Bunt M; Hattersley AT; Gloyn AL; Ellard S;
Hum Mol Genet; 2014 Dec; 23(24):6432-40. PubMed ID: 25015100
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.
Beer NL; van de Bunt M; Colclough K; Lukacs C; Arundel P; Chik CL; Grimsby J; Ellard S; Gloyn AL
J Biol Chem; 2011 May; 286(21):19118-26. PubMed ID: 21454522
[TBL] [Abstract][Full Text] [Related]
14. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
Sagen JV; Odili S; Bjørkhaug L; Zelent D; Buettger C; Kwagh J; Stanley C; Dahl-Jørgensen K; de Beaufort C; Bell GI; Han Y; Grimsby J; Taub R; Molven A; Søvik O; Njølstad PR; Matschinsky FM
Diabetes; 2006 Jun; 55(6):1713-22. PubMed ID: 16731834
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.
Gasperíková D; Tribble ND; Staník J; Hucková M; Misovicová N; van de Bunt M; Valentínová L; Barrow BA; Barák L; Dobránsky R; Bereczková E; Michálek J; Wicks K; Colclough K; Knight JC; Ellard S; Klimes I; Gloyn AL
Diabetes; 2009 Aug; 58(8):1929-35. PubMed ID: 19411616
[TBL] [Abstract][Full Text] [Related]
16. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
[TBL] [Abstract][Full Text] [Related]
17. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Gloyn AL
Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated overexpression of Tcfe3 ameliorates hyperglycaemia in a mouse model of diabetes by upregulating glucokinase in the liver.
Kim MY; Jo SH; Park JM; Kim TH; Im SS; Ahn YH
Diabetologia; 2013 Mar; 56(3):635-43. PubMed ID: 23269357
[TBL] [Abstract][Full Text] [Related]
19. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
